Vaccine And Treatment Evaluation Unit

Buddy Creech, M.D., MPH, associate professor of Pediatrics, has been named director of the Vanderbilt Vaccine Research Program (VVRP) in the Division of Pediatric Infectious Diseases. Read More

The Vanderbilt Vaccine Research Program has received a major contract from the National Institutes of Health to continue its work as one of the nation’s Vaccine and Treatment Evaluation Units. Read More

Vanderbilt University medical researchers are once again part of the nationwide fight to prevent a possible flu pandemic.  There’s a new deadly flu strain called H7N9, that started in eastern China.  Vanderbilt is one of 9 sites preparing to test a new vaccine to protect people against this new strain. Read More

Vanderbilt’s Vaccine and Treatment Evaluation Unit (VTEU) is one of nine U.S. sites funded by the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), to test the effectiveness of a vaccine to protect against the H7N9 bird flu that emerged in China this spring. Read More

Researchers work to prevent possible bird flu pandemic How stars solve mysteries of the universe And conquering the video gaming industry Vandy style? All this and more in this week’s VUCast, Vanderbilt’s online newscast. Watch now. [vucastblurb]… Read More

Vanderbilt’s Vaccine and Treatment Evaluation Unit has received a $1.6 million contract from the National Institutes of Health for a novel approach to vaccine development. Read More